Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

Dana-Farber Cancer Institute
J

Practical Considerations for the Management of Myelofibrosis: JAK Inhibitors and Beyond

By Dana-Farber Cancer Institute FEATURING Jacqueline Garcia
By Dana-Farber Cancer Institute FEATURING Jacqueline Garcia
0 views
May 8, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
MDS and MPN
48:37
Dana-Farber Cancer Institute

Continued Progress in MDS: Novel Therapies and Immune Checkpoint Inh…

Feat. A. Zeidan
16:27
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Update on CHIP and CCUS

Feat. L. Weeks
08:48
Dana-Farber Cancer Institute

Practical Considerations for the Management of Myelofibrosis: JAK In…

Feat. J. Garcia
27:52
Indy Hematology Review

The Oracle of Apollo in Indianapolis: Prognosis and Treatment in MDS

Feat. R. Stone